NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024)
NeuroSense Therapeutics' (NRSN) quarterly EPS (Basic) came in at -$0.1 in Q4 2024, up 88.76% year-over-year from -$0.05 in Q1 2024, and up 38.37% quarter-over-quarter from -$0.15 in Q3 2024.
NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024) Analysis & Trends
NeuroSense Therapeutics has disclosed EPS (Basic) across 4 years of filings, most recently posting -$0.1 for Q4 2024.
- In Q4 2024, EPS (Basic) rose 88.76% year-over-year to -$0.1; the TTM figure through Dec 2024 stood at -$0.53 (up 49.71% YoY), while the FY2025 annual figure was -$0.44, up 20.73% from the prior year.
- EPS (Basic) came in at -$0.1 for Q4 2024 at NeuroSense Therapeutics, up from -$0.15 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.78 in Q4 2021 to a low of -$0.85 in Q4 2023.
- Average EPS (Basic) over 4 years is -$0.2, with a median of -$0.22 recorded in 2024.
- The largest YoY upside for EPS (Basic) was 127.15% in 2023 against a maximum downside of 512.45% in 2023.
- Over 4 years, EPS (Basic) stood at $0.78 in 2021, then tumbled by 117.73% to -$0.14 in 2022, then tumbled by 512.45% to -$0.85 in 2023, then surged by 88.76% to -$0.1 in 2024.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.1 in Q4 2024, -$0.15 in Q3 2024, and -$0.22 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 12.62 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -1.96 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 7.70 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -0.40 |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.22 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.85 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | -0.15 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -0.14 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | 0.78 |
NeuroSense Therapeutics EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=NRSN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();